VYNE Therapeutics
VYNE
#9889
Rank
S$31.92 M
Marketcap
$2.10
Share price
-6.59%
Change (1 day)
-45.19%
Change (1 year)

P/S ratio for VYNE Therapeutics (VYNE)

P/S ratio as of April 2025 (TTM): 48.6

According to VYNE Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.4672. At the end of 2024 the company had a P/S ratio of 93.3.

P/S ratio history for VYNE Therapeutics from 2018 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202493.321.69%
202376.7320.26%
202218.3-1.37%
202118.542.27%
202013.0
2019N/A-100%
20189.00

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA